Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -59.48%393M | -30.43%391M | -36.42%213M | -110.98%-9M | -2,144.44%-202M | 26.63%970M | -6.49%562M | 1,863.16%335M | -69.29%82M | 89.16%-9M |
Net income from continuing operations | -19.24%550M | -55.11%123M | -31.76%101M | 33.08%173M | 18.60%153M | 17.62%681M | 122.76%274M | 7.25%148M | -26.97%130M | -7.86%129M |
Operating gains losses | 4.35%-22M | --0 | -650.00%-11M | 25.00%-3M | 0.00%-8M | -192.00%-23M | -44.44%-13M | -75.00%2M | -123.53%-4M | -188.89%-8M |
Depreciation and amortization | -6.05%326M | -4.55%84M | -3.53%82M | -8.05%80M | -8.05%80M | -3.07%347M | -7.37%88M | -4.49%85M | 0.00%87M | 0.00%87M |
Deferred tax | -7.96%-122M | -109.38%-67M | -42.11%-27M | 65.63%-11M | 43.33%-17M | -5,750.00%-113M | -300.00%-32M | -46.15%-19M | -966.67%-32M | -1,600.00%-30M |
Other non cash items | -65.52%10M | -76.92%3M | 150.00%5M | -130.00%-3M | 25.00%5M | 93.33%29M | 85.71%13M | --2M | --10M | 300.00%4M |
Change In working capital | -2,580.00%-372M | 6.67%240M | -49.07%55M | -109.57%-241M | -109.85%-426M | 106.02%15M | -36.44%225M | 141.38%108M | -538.89%-115M | 37.35%-203M |
-Change in receivables | 185.27%110M | 3,757.14%256M | 362.96%250M | -2,000.00%-19M | -112.99%-377M | -2.38%-129M | -101.71%-7M | 122.69%54M | 103.70%1M | 34.44%-177M |
-Change in inventory | -633.33%-22M | -133.33%-3M | -40.00%-7M | --1M | -85.71%-13M | 86.36%-3M | 200.00%9M | -122.73%-5M | --0 | 74.07%-7M |
-Change in prepaid assets | 21.43%-33M | -200.00%-24M | 220.83%29M | 12.50%-63M | -16.67%25M | -310.00%-42M | 0.00%24M | 52.94%-24M | -280.00%-72M | 328.57%30M |
-Change in payables and accrued expense | -219.32%-315M | -82.19%39M | -286.27%-190M | -400.00%-130M | -9.68%-34M | 4,300.00%264M | 621.43%219M | 155.00%102M | -425.00%-26M | ---31M |
-Change in other working capital | -49.33%-112M | -40.00%-28M | -42.11%-27M | -66.67%-30M | -50.00%-27M | 40.94%-75M | 28.57%-20M | 44.12%-19M | 41.94%-18M | 47.06%-18M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -59.48%393M | -30.43%391M | -36.42%213M | -110.98%-9M | -2,144.44%-202M | 26.63%970M | -6.49%562M | 1,863.16%335M | -69.29%82M | 89.16%-9M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -47.46%-348M | 12.00%-110M | -85.37%-76M | -810.00%-91M | -18.33%-71M | 11.94%-236M | -38.89%-125M | 46.75%-41M | 82.76%-10M | -39.53%-60M |
Capital expenditure reported | -25.68%-367M | 10.94%-114M | -66.04%-88M | -32.35%-90M | -74.42%-75M | -2.82%-292M | -21.90%-128M | 31.17%-53M | -15.25%-68M | 0.00%-43M |
Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | 3,800.00%39M | --2M | --0 | 5,600.00%57M | ---20M |
Net other investing changes | 11.76%19M | 300.00%4M | 0.00%12M | -200.00%-1M | 33.33%4M | 13.33%17M | --1M | --12M | --1M | --3M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -47.46%-348M | 12.00%-110M | -85.37%-76M | -810.00%-91M | -18.33%-71M | 11.94%-236M | -38.89%-125M | 46.75%-41M | 82.76%-10M | -39.53%-60M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 146.17%356M | 565.52%540M | 72.29%-138M | 231.17%101M | -83.75%-147M | -17.17%-771M | 27.95%-116M | -207.41%-498M | 53.05%-77M | 53.22%-80M |
Net issuance payments of debt | 260.63%771M | 2,516.00%604M | 89.65%-44M | 1,185.00%217M | 40.00%-6M | -20.00%-480M | 75.00%-25M | -325.00%-425M | 80.00%-20M | 90.00%-10M |
Net common stock issuance | -116.00%-162M | --0 | -66.67%-35M | -828.57%-65M | -588.89%-62M | -44.23%-75M | -245.45%-38M | -50.00%-21M | 58.82%-7M | 10.00%-9M |
Cash dividends paid | -3.00%-206M | -1.96%-52M | -4.00%-52M | -2.00%-51M | -4.08%-51M | -4.17%-200M | -2.00%-51M | -4.17%-50M | -6.38%-50M | -4.26%-49M |
Net other financing activities | -193.75%-47M | -500.00%-12M | -250.00%-7M | --0 | -133.33%-28M | -14.29%-16M | ---2M | ---2M | --0 | 14.29%-12M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 146.17%356M | 565.52%540M | 72.29%-138M | 231.17%101M | -83.75%-147M | -17.17%-771M | 27.95%-116M | -207.41%-498M | 53.05%-77M | 53.22%-80M |
Net cash flow | ||||||||||
Beginning cash position | -7.92%430M | -90.83%10M | -96.49%11M | -96.86%10M | -7.92%430M | -25.52%467M | -6.84%109M | -16.53%313M | -3.64%318M | -25.52%467M |
Current changes in cash | 1,183.78%401M | 155.76%821M | 99.51%-1M | 120.00%1M | -181.88%-420M | 76.88%-37M | -8.29%321M | 20.93%-204M | -111.11%-5M | 49.83%-149M |
End cash Position | 93.26%831M | 93.26%831M | -90.83%10M | -96.49%11M | -96.86%10M | -7.92%430M | -7.92%430M | -6.84%109M | -16.53%313M | -3.64%318M |
Free cash flow | -96.17%26M | -36.18%277M | -55.67%125M | -807.14%-99M | -432.69%-277M | 40.66%678M | -12.50%434M | 393.75%282M | -93.27%14M | 58.73%-52M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |